Bentur L, Cullinane C, Wilson P, Greenberg M, O'Brodovich H, Silver M M
Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Hum Pathol. 1991 Dec;22(12):1295-8. doi: 10.1016/0046-8177(91)90116-7.
Fatal pulmonary hypertension developed in an infant during the 7-month period in which he received, via a central venous catheter, combination chemotherapy for stage IV neuroblastoma as well as intermittent parenteral feeding. In a lung biopsy and at autopsy, small pulmonary arteries showed diffuse medial hypertrophy and peripheral muscularization, very extensive concentric intimal fibrosis, and focal eccentric fibrosis evolving from organizing thrombi. Pulmonary veins were normal. Hypothetically, chemotherapeutic drug therapy (possibly potentiated either by the parenteral nutrition or simply by the vehicular fluids causing volume loading of the pulmonary circulation) could cause occlusive pulmonary arterial disease by several mechanisms, but the association has not been described previously, although use of such drugs has been reported with pulmonary veno-occlusive disease.
一名婴儿在接受为期7个月的治疗期间发生了致命性肺动脉高压。在此期间,他通过中心静脉导管接受了针对IV期神经母细胞瘤的联合化疗以及间歇性肠外营养。在肺活检和尸检中,小肺动脉显示出弥漫性中层肥厚和外周肌化、非常广泛的同心性内膜纤维化,以及由机化血栓演变而来的局灶性偏心性纤维化。肺静脉正常。从理论上讲,化疗药物治疗(可能因肠外营养或仅仅因载体液体导致肺循环容量负荷而增强作用)可能通过多种机制导致闭塞性肺动脉疾病,但此前尚未有这种关联的描述,尽管已有使用此类药物导致肺静脉闭塞性疾病的报道。